Loss-of-function mutations in EZH2, EED, or SUZ12 occur in a subset of myeloid malignancies, T-cell acute lymphoblastic leukemia (T-ALL), and malignant peripheral nerve sheath tumors (MPNSTs) (Kim and Roberts, 2016). Here, EZH2 is linked to T-cell acute lymphoblastic leukemia.